An update on the diagnosis and treatment of pediatric pulmonary hypertension-Reference-Cited by-同舟云学术

An update on the diagnosis and treatment of pediatric pulmonary hypertension

Published:2020-05-13 Issue:10 Volume:21 Page:1253-1268
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Olguntürk F. Rana¹

Affiliation:

1. Professor of Pediatrics and Pediatric Cardiology, PhD in medical physiology, Former Head of Pediatrics and Pediatric Cardiology in Gazi University Faculty of Medicine. Founder of Pediatric Cardiology and PAH center in Gazi University. Former President of Turkish Association of Pediatric Cardiology and Surgery, Gazi University, Ankara, Turkiye

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1757071

Reference103 articles.

1. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

2. Pulmonary Hypertension in Infants, Children, and Young Adults

3. Pediatric Pulmonary Hypertension

4. Pulmonary arterial hypertension: a comparison between children and adults

5. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Echocardiographic estimation of pulmonary arterial and right atrial pressures in children with congenital heart disease: a comprehensive prospective study and introduction of novel equations;Journal of Cardiovascular Imaging;2024-08-08

2. Impact of Maternal Exercise on Mice Offspring Development, Pulmonary Hypertension, and Vascular Remodeling in Chronic Hypoxia;Medicine & Science in Sports & Exercise;2024-05-15

3. Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis;Value in Health Regional Issues;2023-07

4. A Canadian, retrospective, multicenter experience with selexipag for a heterogeneous group of pediatric pulmonary hypertension patients;Frontiers in Pediatrics;2023-02-28

5. Quantifying side effects and caregiver burdens of pediatric pulmonary hypertension therapies;BMC Pediatrics;2023-01-25